Approval · Notice of Compliance 17006 · 2015
YASMIN PLUS: Notice of Compliance 17006
Issued June 18, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17006
- Date
- June 18, 2015
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Oral contraceptive, acne therapy, improvement in folate status
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| YASMIN PLUS | 02442744 | Cancelled Pre Market |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.03 MG per TAB
- DROSPIRENONE 3 MG per TAB
- LEVOMEFOLATE CALCIUM 0.451 MG per TAB